Bacher A, Eberhardt S, Eisenreich W, Fischer M, Herz S, Illarionov B, Kis K, Richter G
Lehrstuhl für Organische Chemie und Biochemie, Technische Universität München, D-85747 Garching, Germany.
Vitam Horm. 2001;61:1-49. doi: 10.1016/s0083-6729(01)61001-x.
The biosynthesis of one riboflavin molecule requires one molecule of GTP and two molecules of ribulose 5-phosphate. The imidazole ring of GTP is hydrolytically opened, yielding a 4,5-diaminopyrimidine that is converted to 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione by a sequence of deamination, side chain reduction, and dephosphorylation. Condensation of 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione with 3,4-dihydroxy-2-butanone 4-phosphate obtained from ribulose 5-phosphate affords 6,7-dimethyl-8-ribityllumazine. Dismutation of the lumazine derivative yields riboflavin and 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione, which is recycled in the biosynthetic pathway. Two reaction steps in the biosynthetic pathway catalyzed by 3,4-dihydroxy-2-butanone 4-phosphate synthase and riboflavin synthase are mechanistically very complex. The enzymes of the riboflavin pathway are potential targets for antibacterial agents.
一个核黄素分子的生物合成需要一分子鸟苷三磷酸(GTP)和两分子5-磷酸核糖。GTP的咪唑环通过水解打开,产生一个4,5-二氨基嘧啶,该嘧啶通过一系列脱氨基、侧链还原和去磷酸化反应转化为5-氨基-6-核糖基氨基-2,4(1H,3H)-嘧啶二酮。5-氨基-6-核糖基氨基-2,4(1H,3H)-嘧啶二酮与从5-磷酸核糖获得的3,4-二羟基-2-丁酮4-磷酸缩合,生成6,7-二甲基-8-核糖基异咯嗪。异咯嗪衍生物的歧化反应产生核黄素和5-氨基-6-核糖基氨基-2,4(1H,3H)-嘧啶二酮,后者在生物合成途径中循环利用。由3,4-二羟基-2-丁酮4-磷酸合酶和核黄素合酶催化的生物合成途径中的两个反应步骤在机制上非常复杂。核黄素途径的酶是抗菌剂的潜在作用靶点。